Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Mosaicism in prenatal samples is a complex but important phenomenon. Optimal use of QF-PCR will identify most clinically significant cases of mosaicism, and also provide additional information regarding the origin of the abnormal cell line.
Authored by Dr. Kathy Mann, pioneer in prenatal QF-PCR analysis, it includes useful sections on: assay design, sample processing, limitations and much more..
Mosaicism in prenatal samples is a complex but important phenomenon. Optimal use of QF-PCR will identify most clinically significant cases of mosaicism, and also provide additional information regarding the origin of the abnormal cell line.
Authored by Dr. Kathy Mann, pioneer in prenatal QF-PCR analysis, it includes useful sections on: assay design, sample processing, limitations and much more..
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
Read More
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
Read More